ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,674,509 | -65.0% | 581,415 | -50.8% | 0.00% | -100.0% |
| Q2 2023 | $7,636,663 | +11.4% | 1,182,146 | +30.0% | 0.00% | 0.0% |
| Q1 2023 | $6,856,905 | +6.5% | 909,404 | +43.1% | 0.00% | 0.0% |
| Q4 2022 | $6,437,959 | -7.4% | 635,534 | -9.6% | 0.00% | 0.0% |
| Q3 2022 | $6,951,000 | +36.3% | 703,010 | +46.8% | 0.00% | 0.0% |
| Q2 2022 | $5,101,000 | +33.0% | 479,003 | +21.8% | 0.00% | 0.0% |
| Q1 2022 | $3,834,000 | -46.5% | 393,136 | -21.5% | 0.00% | 0.0% |
| Q4 2021 | $7,165,000 | -51.4% | 500,970 | -31.9% | 0.00% | -50.0% |
| Q3 2021 | $14,750,000 | +16.8% | 736,019 | +28.2% | 0.00% | 0.0% |
| Q2 2021 | $12,633,000 | +414.0% | 574,193 | +693.5% | 0.00% | – |
| Q1 2021 | $2,458,000 | +1983.1% | 72,365 | +2353.1% | 0.00% | – |
| Q4 2020 | $118,000 | – | 2,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |